Host Range & EOP Profiles You Can Make Decisions With
Overview
Data Presentation
Experimental Design
Biases & Fixes
Published Data
FAQs
Related Sections
Generating reliable and reproducible phage data begins with the core principles outlined in our QC & Analytics hub. Taking that quality-first approach a step further, Creative Biolabs helps you optimize your host range and Efficiency of Plating (EOP) assays. We are committed to partnering with you to effectively evaluate bacterial susceptibility, measure lytic strength, validate repeatability, and confidently select the optimal phage sets for downstream applications.
Host Range and EOP Profiles That Answer Real Buyer Questions
A host range table is useful only when it supports a clear next step. A decision-ready report should answer three practical questions with simple rules and easy-to-read outputs.
1. Host Range Coverage
Which Bacteria Are Covered?
Broad is not a number. Coverage must be defined by your strain panel and shown by meaningful groups, such as species, lineage, capsule type, or source.
- Coverage summaries by group, not only an overall hit rate.
- Separate calls for fast screening results and plaque-confirmed infection.
- Clear notes on detection limits and what was not tested.
Fast Scan Tool: Phage Spot Test
2. EOP Efficiency
How Strong Is the Infection?
EOP is reported as PFU on a test host divided by PFU on a reference host. This supports clear comparisons across hosts and helps prevent decisions based on simple yes or no calls.
- Used for ranking, selecting leads, and building combinations.
- Requires plaque-based counting under controlled conditions.
Quantitative Tool: Phage Plaque Assay
3. Combination Readiness
Can You Combine Without Guessing?
Combination design works best when it is based on evidence. The goal is to close gaps while avoiding heavy overlap and weak members.
- Complement checks: Phages that add new coverage at useful EOP levels.
- Overlap checks: Phages that add little new value.
- Stability checks: Phages active only under narrow conditions.
Context Tool: Phage-host Interaction Analysis
Project Tip: If you already know the strains that matter most, send just those IDs first. A panel can be built around them while keeping enough diversity. Additionally, provide your candidate phage list, known reference hosts, and your primary goal (e.g., top lead, broad mapping) to accelerate the project intake.
EOP Grading and Interpretation That Helps Decisions
EOP gives a simple, useful comparison under defined conditions. It supports statements like "the phage plates far less well on one host than on its reference host." It does not explain why. Low EOP can come from binding limits, restriction systems, abortive infection, host state, or small changes in method. A safe approach is to use EOP tiers for decisions and keep raw values and replicate notes for transparency.
A Practical Tiering Starting Point
Moderate
10-3 ≤ EOP < 10-1
No Detectable
EOP < 10-5
(within limits)
Tiering works best when you also state how you handle replicate differences. For example, use the median EOP and highlight cases where replicates fall into more than one tier. If your team already has internal cutoffs, simply share them with us, and the report will be tailored to follow your rubric.
Host Range and EOP Data Presentation That Supports Decisions
Host Range and EOP Heatmaps Built for Fast Review
A heatmap should be readable without long explanation. Good heatmaps often include:
- Separate layers for fast screening and plaque-based EOP confirmation.
- A clear "no data" label that is different from "no infection".
- Strain grouping by key metadata.
- A tier legend that matches your rules and detection limits.
Clustering can help reveal patterns that matter for pairing and gap closing.
Layered Summary: Different Views for Different Readers
A decision-ready report usually includes:
- A one-page summary with coverage by tier, key gaps, top candidates, and a suggested next step.
- Coverage notes by strain groups.
- Short profile cards for each phage with breadth, strength, and repeatability.
- Raw tables with PFU counts, EOP math, replicate notes, and QC items.
For teams that choose portfolios, a small set with good complement coverage is often the most useful output.
Experimental Design That Produces Clear Results
To ensure the data generated translates smoothly into actionable insights, our experimental design rigorously controls three core aspects.
1 Panel Design
Choose a Panel That Matches Real Diversity
Your panel shapes your conclusion. If the panel is biased, the host range will look wider or narrower than it really is. A practical panel includes:
- Project-relevant strains (e.g., your own isolates).
- Diversity strains covering key groups and traits.
- A reference host for each phage for EOP.
- Negative controls.
2 Thresholds
Set the Rules Before Running
Many host range datasets fail review because calls were made after the results were seen. Decision-ready work sets the rules first:
- Biological replicates (independent host cultures).
- Technical replicates (repeat plates and dilution coverage).
- A clear pass rule for productive infection.
3 Standardization
Control Variables That Change EOP
EOP is affected by biology and method. For comparable data, standardize:
- Host growth window.
- Media and ions.
- Soft agar percentage and plate handling.
- Adsorption time and temperature.
- Incubation time for plaque readout.
Using Host Range and EOP Profiles to Choose the Next Step
Prioritize With Breadth and Strength Together
A common mistake is picking the broadest candidate when most hits are weak. A better approach ranks candidates by:
- Coverage at High and Moderate tiers.
- Repeatability across replicate cultures and days.
- Stability under small condition changes, when tested.
To add kinetic context, use One-step Growth Curve of Phage for latent period and burst size, which can explain differences between candidates with similar EOP.
Combine to Close Gaps
A rational combination plan aims for the most new coverage per added member. The matrix helps you:
- Find resistant groups and target them with specific members.
- Avoid members that mainly add Low-tier hits.
- Keep backup options only where they reduce risk in priority groups.
When you need deeper insight to support pairing, Phage-host Interaction Analysis can help link patterns to likely interaction reasons.
Use Phenotype Evidence to Gate Deeper Work
Deeper profiling is most efficient after a phenotype gate rather than before it. A practical path is:
- Fast mapping to find credible interactions.
- Plaque-based EOP confirmation for decision relevance.
- Optional growth curves for portfolio strength.
If you want a full screen-to-decision package, sharing your decision endpoint up front helps shape the most efficient plan.
Discuss Your Project
Common Host Range and EOP Biases and How to Fix Them
Clearing can happen without productive infection. Fix this by using dilution logic and confirming with plaques and EOP. A common workflow is Phage Spot Test for triage, then Phage Plaque Assay for decisions.
EOP is meaningful only when the reference host and conditions stay the same. Fix this by locking the reference host per phage and using documented conditions.
Rare plaques can be real or noise. Fix this by setting replicate rules and repeating with fresh host cultures for borderline cases.
Convenience panels can overrepresent one group. Fix this by stratifying and reporting coverage by subgroup.
Mucoidy, capsule switching, and growth state can change results. Fix this by tracking key phenotype notes and standardizing growth windows.
Published Data: A Clear Example of Host Range Plus EOP You Can Act On
A strong published example that matches this page goal is the BASEL phage collection study, which separates lysis host range from plaque-based EOP and shows how to present both in a decision-friendly way. The authors use a simple schematic to explain the difference between qualitative spot testing and quantitative EOP, then report host range results with EOP averages and variation across independent repeats.
Fig.1 Host range and EOP workflow and example outputs for lysis host range vs plaquing host range across enterobacteria.1
FAQs on Host Range and EOP
Q: What is the difference between host range and EOP?
A: Host range tells you which hosts show susceptibility under defined conditions. EOP tells you how efficiently plaques form on each susceptible host compared with a reference host, which supports ranking and selection.
Q: Can a spot test alone define coverage?
A: Spot tests are useful for triage but can overcall positives. For strong coverage claims, confirm key hits with plaques and EOP under standardized conditions.
Q: How many strains should be in a host range panel?
A: Enough to reflect the diversity that matters for your project and the diversity that could change your conclusions. Many programs use a "must-cover" core plus a stratified diversity set.
Q: What EOP threshold should define "covered"?
A: There is no universal cutoff. Thresholds should match your goal and your tolerance for weak performance. Tiering is often more useful than one cutoff.
Q: Why do results vary across replicates or days?
A: Common reasons include host growth state changes, plating condition shifts, and borderline interactions sensitive to small changes. Fixed calling rules and standardized conditions reduce this.
Q: How do I choose combinations from an EOP heatmap?
A: Choose members that add new High or Moderate coverage and avoid heavy overlap. Favor repeatable members and use the matrix to close gaps.
Q: When should I add a one-step growth curve?
A: When EOP alone does not explain why a candidate ranks well or when you need kinetic context. Latent period and burst size can help confirm portfolio strength.
Reference:
- Maffei, E., Shaidullina, A., Burkolter, M., Heyer, Y., Estermann, F., Druelle, V., et al. "Systematic exploration of Escherichia coli phage–host interactions with the BASEL phage collection." PLOS Biology 19.11 (2021): e3001424. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pbio.3001424
Please kindly note that our services can only be used to support research purposes (Not for clinical use).